[Introducing International State-of-the-Art Clinical Microbiologic Technologies to Japanese Clinical Laboratories--Opening Remarks].
Internationally, recent progress in clinical microbiology has involved adapting for multi-drug-resistant organisms (MDROs) such as carbapenemase-producing Enterobacteriaceae (CRE) using selective culture media and the active surveillance test using real-time PCR, matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) technology for bacterial identification, and molecular epidemiological tools such as multi-locus sequence typing (MLST). In this symposium, we discussed updating to state-of-the-art clinical microbiologic technologies in Japanese clinical laboratories.